APO Research
Talk to an analyst

APO RESEARCH · REPORT

Veterinary Vaccine

Vaccines are products designed to trigger protective immune responses and prepare the immune system to fight future infections from disease-causing agents. Vaccines stimulate the immune system’s production of antibodies that identify and destroy disease-causing organisms that enter the body. Vaccines provide immunity against one or several diseases that can lessen the severity or prevent certain diseases altogether. In this report, we study the vaccine used for animals.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Vaccines are products designed to trigger protective immune responses and prepare the immune system to fight future infections from disease-causing agents. Vaccines stimulate the immune system’s production of antibodies that identify and destroy disease-causing organisms that enter the body. Vaccines provide immunity against one or several diseases that can lessen the severity or prevent certain diseases altogether. In this report, we study the vaccine used for animals.

Selected research

Market Structure

Global Veterinary Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

9 January 2026193 pages

Choose your research edition.

Industry ResearchVeterinary Vaccine Industry Research Report 2026151 pages · $2,950 USDIndustry Growth & TrendsGlobal Veterinary Vaccine Industry Growth and Trends Forecast to 2032125 pages · $3,450 USDMarket StructureGlobal Veterinary Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Veterinary Vaccine Market Outlook and Growth Opportunities 2026210 pages · $4,250 USDMarket Analysis & ForecastGlobal Veterinary Vaccine Market Analysis and Forecast 2026-2032211 pages · $4,950 USD

Market perspective

Vaccines are products designed to trigger protective immune responses and prepare the immune system to fight future infections from disease-causing agents. Vaccines stimulate the immune system’s production of antibodies that identify and destroy disease-causing organisms that enter the body. Vaccines provide immunity against one or several diseases that can lessen the severity or prevent certain diseases altogether. In this report, we study the vaccine used for animals.

Global Veterinary Vaccine key players include Merck, Boehringer Ingelheim, Zoetis, Ceva, Elanco, etc. Global top five manufacturers hold a share about 75%. North America and Asia Pacific is the largest market, both with a share about 30%, followed by Europe, with a share about 25 percent. In terms of product, Live Attenuated Vaccines is the largest segment, with a share about 60%. And in terms of application, the largest application is Dog & Cat, followed by Livestock, Swine, Chicken, etc.

This report provides an overview of the global Veterinary Vaccine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Veterinary Vaccine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Veterinary Vaccine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Veterinary Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.

Veterinary Vaccine Segment by Company

Merck

Zoetis

Boehringer Ingelheim

Ceva

CAHIC

HVRI

Ringpu Biology

Yebio

DHN

WINSUN

Elanco

Virbac

Jinyu Bio-Technology

ChengDu Tecbond

CAVAC

Kyoto Biken Laboratories

FATRO

Vaksindo

Bio-Labs

Avimex Animal Health

MEVAC

Biovac

Atafen

Dyntec

BioTestLab

RVSRI

Medion

Veterinary Vaccine Segment by Type

Live Attenuated Vaccines

Inactivated Vaccines

Others

Veterinary Vaccine Segment by Application

Livestock

Swine

Chicken

Dog & Cat

Others

Veterinary Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Veterinary Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Veterinary Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Veterinary Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Veterinary Vaccine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Veterinary Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Veterinary Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Veterinary Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Veterinary Vaccine Industry Trends Table 2. Veterinary Vaccine Industry Drivers Table 3. Veterinary Vaccine Industry Opportunities and Challenges Table 4. Veterinary Vaccine Industry Restraints Table 5. Global Veterinary Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Veterinary Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Veterinary Vaccine Sales by Manufacturers (M Doses) & (2021-2026) Table 8. Global Veterinary Vaccine Sales Market Share by Manufacturers Table 9. Global Veterinary Vaccine Average Sales Price (USD/Doses) of Manufacturers (2021-2026) Table 10. Global Veterinary Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Veterinary Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Veterinary Vaccine Manufacturers, Product Type & Application Table 13. Global Veterinary Vaccine Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Veterinary Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Live Attenuated Vaccines Table 17. Major Manufacturers of Inactivated Vaccines Table 18. Major Manufacturers of Others Table 19. Global Veterinary Vaccine Sales by Type 2021 VS 2025 VS 2032 (M Doses) Table 20. Global Veterinary Vaccine Sales by Type (2021-2026) & (M Doses) Table 21. Global Veterinary Vaccine Sales by Type (2027-2032) & (M Doses) Table 22. Global Veterinary Vaccine Sales Market Share by Type (2021-2026) Table 23. Global Veterinary Vaccine Sales Market Share by Type (2027-2032) Table 24. Global Veterinary Vaccine Revenue by Type 2021 VS 2025 VS 2032 (M Doses) Table 25. Global Veterinary Vaccine Revenue by Type (2021-2026) & (M Doses) Table 26. Global Veterinary Vaccine Revenue by Type (2027-2032) & (M Doses) Table 27. Global Veterinary Vaccine Revenue Market Share by Type (2021-2026) Table 28. Global Veterinary Vaccine Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Livestock Table 30. Major Manufacturers of Swine Table 31. Major Manufacturers of Chicken Table 32. Major Manufacturers of Dog & Cat Table 33. Major Manufacturers of Others Table 34. Global Veterinary Vaccine Sales by Application 2021 VS 2025 VS 2032 (M Doses) Table 35. Global Veterinary Vaccine Sales by Application (2021-2026) & (M Doses) Table 36. Global Veterinary Vaccine Sales by Application (2027-2032) & (M Doses) Table 37. Global Veterinary Vaccine Sales Market Share by Application (2021-2026) Table 38. Global Veterinary Vaccine Sales Market Share by Application (2027-2032) Table 39. Global Veterinary Vaccine Revenue by Application 2021 VS 2025 VS 2032 (M Doses) Table 40. Global Veterinary Vaccine Revenue by Application (2021-2026) & (M Doses) Table 41. Global Veterinary Vaccine Revenue by Application (2027-2032) & (M Doses) Table 42. Global Veterinary Vaccine Revenue Market Share by Application (2021-2026) Table 43. Global Veterinary Vaccine Revenue Market Share by Application (2027-2032) Table 44. Global Veterinary Vaccine Sales by Region: 2021 VS 2025 VS 2032 (M Doses) Table 45. Global Veterinary Vaccine Sales by Region (2021-2026) & (M Doses) Table 46. Global Veterinary Vaccine Sales Market Share by Region (2021-2026) Table 47. Global Veterinary Vaccine Sales Forecasted by Region (2027-2032) & (M Doses) Table 48. Global Veterinary Vaccine Sales Forecasted Market Share by Region (2027-2032) Table 49. North America Veterinary Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Doses) Table 50. North America Veterinary Vaccine Sales by Country (2021-2026) & (M Doses) Table 51. North America Veterinary Vaccine Sales by Country (2027-2032) & (M Doses) Table 52. Europe Veterinary Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Doses) Table 53. Europe Veterinary Vaccine Sales by Country (2021-2026) & (M Doses) Table 54. Europe Veterinary Vaccine Sales by Country (2027-2032) & (M Doses) Table 55. Asia Pacific Veterinary Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Doses) Table 56. Asia Pacific Veterinary Vaccine Sales by Country (2021-2026) & (M Doses) Table 57. Asia Pacific Veterinary Vaccine Sales by Country (2027-2032) & (M Doses) Table 58. South America, Middle East and Africa Veterinary Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Doses) Table 59. South America, Middle East and Africa Veterinary Vaccine Sales by Country (2021-2026) & (M Doses) Table 60. South America, Middle East and Africa Veterinary Vaccine Sales by Country (2027-2032) & (M Doses) Table 61. Global Veterinary Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global Veterinary Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 63. Global Veterinary Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 64. Global Veterinary Vaccine Revenue Market Share by Region (2021-2026) Table 65. Global Veterinary Vaccine Revenue Market Share by Region (2027-2032) Table 66. Merck Company Information Table 67. Merck Business Overview Table 68. Merck Veterinary Vaccine Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Merck Veterinary Vaccine Product Portfolio Table 70. Merck Recent Development Table 71. Zoetis Company Information Table 72. Zoetis Business Overview Table 73. Zoetis Veterinary Vaccine Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Zoetis Veterinary Vaccine Product Portfolio Table 75. Zoetis Recent Development Table 76. Boehringer Ingelheim Company Information Table 77. Boehringer Ingelheim Business Overview Table 78. Boehringer Ingelheim Veterinary Vaccine Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Boehringer Ingelheim Veterinary Vaccine Product Portfolio Table 80. Boehringer Ingelheim Recent Development Table 81. Ceva Company Information Table 82. Ceva Business Overview Table 83. Ceva Veterinary Vaccine Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Ceva Veterinary Vaccine Product Portfolio Table 85. Ceva Recent Development Table 86. CAHIC Company Information Table 87. CAHIC Business Overview Table 88. CAHIC Veterinary Vaccine Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. CAHIC Veterinary Vaccine Product Portfolio Table 90. CAHIC Recent Development Table 91. HVRI Company Information Table 92. HVRI Business Overview Table 93. HVRI Veterinary Vaccine Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 94. HVRI Veterinary Vaccine Product Portfolio Table 95. HVRI Recent Development Table 96. Ringpu Biology Company Information Table 97. Ringpu Biology Business Overview Table 98. Ringpu Biology Veterinary Vaccine Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 99. Ringpu Biology Veterinary Vaccine Product Portfolio Table 100. Ringpu Biology Recent Development Table 101. Yebio Company Information Table 102. Yebio Business Overview Table 103. Yebio Veterinary Vaccine Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 104. Yebio Veterinary Vaccine Product Portfolio Table 105. Yebio Recent Development Table 106. DHN Company Information Table 107. DHN Business Overview Table 108. DHN Veterinary Vaccine Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 109. DHN Veterinary Vaccine Product Portfolio Table 110. DHN Recent Development Table 111. WINSUN Company Information Table 112. WINSUN Business Overview Table 113. WINSUN Veterinary Vaccine Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 114. WINSUN Veterinary Vaccine Product Portfolio Table 115. WINSUN Recent Development Table 116. Elanco Company Information Table 117. Elanco Business Overview Table 118. Elanco Veterinary Vaccine Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 119. Elanco Veterinary Vaccine Product Portfolio Table 120. Elanco Recent Development Table 121. Virbac Company Information Table 122. Virbac Business Overview Table 123. Virbac Veterinary Vaccine Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 124. Virbac Veterinary Vaccine Product Portfolio Table 125. Virbac Recent Development Table 126. Jinyu Bio-Technology Company Information Table 127. Jinyu Bio-Technology Business Overview Table 128. Jinyu Bio-Technology Veterinary Vaccine Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 129. Jinyu Bio-Technology Veterinary Vaccine Product Portfolio Table 130. Jinyu Bio-Technology Recent Development Table 131. ChengDu Tecbond Company Information Table 132. ChengDu Tecbond Business Overview Table 133. ChengDu Tecbond Veterinary Vaccine Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 134. ChengDu Tecbond Veterinary Vaccine Product Portfolio Table 135. ChengDu Tecbond Recent Development Table 136. CAVAC Company Information Table 137. CAVAC Business Overview Table 138. CAVAC Veterinary Vaccine Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 139. CAVAC Veterinary Vaccine Product Portfolio Table 140. CAVAC Recent Development Table 141. Kyoto Biken Laboratories Company Information Table 142. Kyoto Biken Laboratories Business Overview Table 143. Kyoto Biken Laboratories Veterinary Vaccine Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 144. Kyoto Biken Laboratories Veterinary Vaccine Product Portfolio Table 145. Kyoto Biken Laboratories Recent Development Table 146. FATRO Company Information Table 147. FATRO Business Overview Table 148. FATRO Veterinary Vaccine Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 149. FATRO Veterinary Vaccine Product Portfolio Table 150. FATRO Recent Development Table 151. Vaksindo Company Information Table 152. Vaksindo Business Overview Table 153. Vaksindo Veterinary Vaccine Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 154. Vaksindo Veterinary Vaccine Product Portfolio Table 155. Vaksindo Recent Development Table 156. Bio-Labs Company Information Table 157. Bio-Labs Business Overview Table 158. Bio-Labs Veterinary Vaccine Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 159. Bio-Labs Veterinary Vaccine Product Portfolio Table 160. Bio-Labs Recent Development Table 161. Avimex Animal Health Company Information Table 162. Avimex Animal Health Business Overview Table 163. Avimex Animal Health Veterinary Vaccine Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 164. Avimex Animal Health Veterinary Vaccine Product Portfolio Table 165. Avimex Animal Health Recent Development Table 166. MEVAC Company Information Table 167. MEVAC Business Overview Table 168. MEVAC Veterinary Vaccine Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 169. MEVAC Veterinary Vaccine Product Portfolio Table 170. MEVAC Recent Development Table 171. Biovac Company Information Table 172. Biovac Business Overview Table 173. Biovac Veterinary Vaccine Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 174. Biovac Veterinary Vaccine Product Portfolio Table 175. Biovac Recent Development Table 176. Atafen Company Information Table 177. Atafen Business Overview Table 178. Atafen Veterinary Vaccine Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 179. Atafen Veterinary Vaccine Product Portfolio Table 180. Atafen Recent Development Table 181. Dyntec Company Information Table 182. Dyntec Business Overview Table 183. Dyntec Veterinary Vaccine Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 184. Dyntec Veterinary Vaccine Product Portfolio Table 185. Dyntec Recent Development Table 186. BioTestLab Company Information Table 187. BioTestLab Business Overview Table 188. BioTestLab Veterinary Vaccine Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 189. BioTestLab Veterinary Vaccine Product Portfolio Table 190. BioTestLab Recent Development Table 191. RVSRI Company Information Table 192. RVSRI Business Overview Table 193. RVSRI Veterinary Vaccine Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 194. RVSRI Veterinary Vaccine Product Portfolio Table 195. RVSRI Recent Development Table 196. Medion Company Information Table 197. Medion Business Overview Table 198. Medion Veterinary Vaccine Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 199. Medion Veterinary Vaccine Product Portfolio Table 200. Medion Recent Development Table 201. Key Raw Materials Table 202. Raw Materials Key Suppliers Table 203. Veterinary Vaccine Distributors List Table 204. Veterinary Vaccine Customers List Table 205. Research Programs/Design for This Report Table 206. Authors List of This Report Table 207. Secondary Sources Table 208. Primary Sources List of Figures Figure 1. Veterinary Vaccine Product Image Figure 2. Global Veterinary Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Veterinary Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Veterinary Vaccine Sales (2021-2032) & (M Doses) Figure 5. Global Veterinary Vaccine Average Price (USD/Doses) & (2021-2032) Figure 6. Global Top 5 and 10 Veterinary Vaccine Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Live Attenuated Vaccines Image Figure 9. Inactivated Vaccines Image Figure 10. Others Image Figure 11. Global Veterinary Vaccine Sales by Type (2021 VS 2025 VS 2032) & (M Doses) Figure 12. Global Veterinary Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Veterinary Vaccine Sales Market Share by Type (2021-2032) Figure 14. Global Veterinary Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (M Doses) Figure 15. Global Veterinary Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Veterinary Vaccine Revenue Market Share by Type (2021-2032) Figure 17. Livestock Image Figure 18. Swine Image Figure 19. Chicken Image Figure 20. Dog & Cat Image Figure 21. Others Image Figure 22. Global Veterinary Vaccine Sales by Application (2021 VS 2025 VS 2032) & (M Doses) Figure 23. Global Veterinary Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 24. Global Veterinary Vaccine Sales Market Share by Application (2021-2032) Figure 25. Global Veterinary Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (M Doses) Figure 26. Global Veterinary Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 27. Global Veterinary Vaccine Revenue Market Share by Application (2021-2032) Figure 28. North America Veterinary Vaccine Sales and Growth Rate (2021-2032) & (M Doses) Figure 29. North America Veterinary Vaccine Sales Market Share by Country (2021-2032) Figure 30. U.S. Veterinary Vaccine Sales and Growth Rate (2021-2032) & (M Doses) Figure 31. Canada Veterinary Vaccine Sales and Growth Rate (2021-2032) & (M Doses) Figure 32. Mexico Veterinary Vaccine Sales and Growth Rate (2021-2032) & (M Doses) Figure 33. Europe Veterinary Vaccine Sales and Growth Rate (2021-2032) & (M Doses) Figure 34. Europe Veterinary Vaccine Sales Market Share by Country (2021-2032) Figure 35. Germany Veterinary Vaccine Sales and Growth Rate (2021-2032) & (M Doses) Figure 36. France Veterinary Vaccine Sales and Growth Rate (2021-2032) & (M Doses) Figure 37. U.K. Veterinary Vaccine Sales and Growth Rate (2021-2032) & (M Doses) Figure 38. Italy Veterinary Vaccine Sales and Growth Rate (2021-2032) & (M Doses) Figure 39. Netherlands Veterinary Vaccine Sales and Growth Rate (2021-2032) & (M Doses) Figure 40. Asia Pacific Veterinary Vaccine Sales and Growth Rate (2021-2032) & (M Doses) Figure 41. Asia Pacific Veterinary Vaccine Sales Market Share by Country (2021-2032) Figure 42. China Veterinary Vaccine Sales and Growth Rate (2021-2032) & (M Doses) Figure 43. Japan Veterinary Vaccine Sales and Growth Rate (2021-2032) & (M Doses) Figure 44. South Korea Veterinary Vaccine Sales and Growth Rate (2021-2032) & (M Doses) Figure 45. Southeast Asia Veterinary Vaccine Sales and Growth Rate (2021-2032) & (M Doses) Figure 46. India Veterinary Vaccine Sales and Growth Rate (2021-2032) & (M Doses) Figure 47. Australia Veterinary Vaccine Sales and Growth Rate (2021-2032) & (M Doses) Figure 48. South America, Middle East and Africa Veterinary Vaccine Sales and Growth Rate (2021-2032) & (M Doses) Figure 49. South America, Middle East and Africa Veterinary Vaccine Sales Market Share by Country (2021-2032) Figure 50. Brazil Veterinary Vaccine Sales and Growth Rate (2021-2032) & (M Doses) Figure 51. South Africa Veterinary Vaccine Sales and Growth Rate (2021-2032) & (M Doses) Figure 52. Saudi Arabia Veterinary Vaccine Sales and Growth Rate (2021-2032) & (M Doses) Figure 53. Turkey Veterinary Vaccine Sales and Growth Rate (2021-2032) & (M Doses) Figure 54. Argentina Veterinary Vaccine Sales and Growth Rate (2021-2032) & (M Doses) Figure 55. UAE Veterinary Vaccine Sales and Growth Rate (2021-2032) & (M Doses) Figure 56. Egypt Veterinary Vaccine Sales and Growth Rate (2021-2032) & (M Doses) Figure 57. Chile Veterinary Vaccine Sales and Growth Rate (2021-2032) & (M Doses) Figure 58. Global Veterinary Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Global Veterinary Vaccine Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 60. North America Veterinary Vaccine Revenue (2021-2032) & (US$ Million) Figure 61. North America Veterinary Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Europe Veterinary Vaccine Revenue (2021-2032) & (US$ Million) Figure 63. Europe Veterinary Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asia-Pacific Veterinary Vaccine Revenue (2021-2032) & (US$ Million) Figure 65. Asia-Pacific Veterinary Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. South America, Middle East and Africa Veterinary Vaccine Revenue (2021-2032) & (US$ Million) Figure 67. South America, Middle East and Africa Veterinary Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Veterinary Vaccine Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Veterinary Vaccine Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Live Attenuated Vaccines
  • Inactivated Vaccines
  • Others
Applications
  • Livestock
  • Swine
  • Chicken
  • Dog & Cat
  • Others
Companies covered
  • Merck
  • Zoetis
  • Boehringer Ingelheim
  • Ceva
  • CAHIC
  • HVRI
  • Ringpu Biology
  • Yebio
  • DHN
  • WINSUN
  • Elanco
  • Virbac
  • Jinyu Bio-Technology
  • ChengDu Tecbond
  • CAVAC
  • Kyoto Biken Laboratories
  • FATRO
  • Vaksindo
  • Bio-Labs
  • Avimex Animal Health
  • MEVAC
  • Biovac
  • Atafen
  • Dyntec
  • BioTestLab
  • RVSRI
  • Medion

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Veterinary Vaccine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Veterinary Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Veterinary Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Veterinary Vaccine Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Veterinary Vaccine Market Dynamics
  1. 2.1 Veterinary Vaccine Industry Trends
  2. 2.2 Veterinary Vaccine Industry Drivers
  3. 2.3 Veterinary Vaccine Industry Opportunities and Challenges
  4. 2.4 Veterinary Vaccine Industry Restraints
3 Veterinary Vaccine Market by Manufacturers
  1. 3.1 Global Veterinary Vaccine Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Veterinary Vaccine Sales by Manufacturers (2021-2026)
  3. 3.3 Global Veterinary Vaccine Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Veterinary Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Veterinary Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Veterinary Vaccine Manufacturers, Product Type & Application
  7. 3.7 Global Veterinary Vaccine Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Veterinary Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Veterinary Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Veterinary Vaccine Tier 1, Tier 2, and Tier 3
4 Veterinary Vaccine Market by Type
  1. 4.1 Veterinary Vaccine Type Introduction
  2. 4.1.1 Live Attenuated Vaccines
  3. 4.1.2 Inactivated Vaccines
  4. 4.1.3 Others
  5. 4.2 Global Veterinary Vaccine Sales by Type
  6. 4.2.1 Global Veterinary Vaccine Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Veterinary Vaccine Sales by Type (2021-2032)
  8. 4.2.3 Global Veterinary Vaccine Sales Market Share by Type (2021-2032)
  9. 4.3 Global Veterinary Vaccine Revenue by Type
  10. 4.3.1 Global Veterinary Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Veterinary Vaccine Revenue by Type (2021-2032)
  12. 4.3.3 Global Veterinary Vaccine Revenue Market Share by Type (2021-2032)
5 Veterinary Vaccine Market by Application
  1. 5.1 Veterinary Vaccine Application Introduction
  2. 5.1.1 Livestock
  3. 5.1.2 Swine
  4. 5.1.3 Chicken
  5. 5.1.4 Dog & Cat
  6. 5.1.5 Others
  7. 5.2 Global Veterinary Vaccine Sales by Application
  8. 5.2.1 Global Veterinary Vaccine Sales by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Veterinary Vaccine Sales by Application (2021-2032)
  10. 5.2.3 Global Veterinary Vaccine Sales Market Share by Application (2021-2032)
  11. 5.3 Global Veterinary Vaccine Revenue by Application
  12. 5.3.1 Global Veterinary Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Veterinary Vaccine Revenue by Application (2021-2032)
  14. 5.3.3 Global Veterinary Vaccine Revenue Market Share by Application (2021-2032)
6 Global Veterinary Vaccine Sales by Region
  1. 6.1 Global Veterinary Vaccine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Veterinary Vaccine Sales by Region (2021-2032)
  3. 6.2.1 Global Veterinary Vaccine Sales by Region (2021-2026)
  4. 6.2.2 Global Veterinary Vaccine Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Veterinary Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Veterinary Vaccine Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Veterinary Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Veterinary Vaccine Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Veterinary Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Veterinary Vaccine Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Veterinary Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Veterinary Vaccine Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Veterinary Vaccine Revenue by Region
  1. 7.1 Global Veterinary Vaccine Revenue by Region
  2. 7.1.1 Global Veterinary Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Veterinary Vaccine Revenue by Region (2021-2026)
  4. 7.1.3 Global Veterinary Vaccine Revenue by Region (2027-2032)
  5. 7.1.4 Global Veterinary Vaccine Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Veterinary Vaccine Revenue (2021-2032)
  8. 7.2.2 North America Veterinary Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Veterinary Vaccine Revenue (2021-2032)
  11. 7.3.2 Europe Veterinary Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Veterinary Vaccine Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Veterinary Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Veterinary Vaccine Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Veterinary Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Merck
  2. 8.1.1 Merck Company Information
  3. 8.1.2 Merck Business Overview
  4. 8.1.3 Merck Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Merck Veterinary Vaccine Product Portfolio
  6. 8.1.5 Merck Recent Developments
  7. 8.2 Zoetis
  8. 8.2.1 Zoetis Company Information
  9. 8.2.2 Zoetis Business Overview
  10. 8.2.3 Zoetis Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Zoetis Veterinary Vaccine Product Portfolio
  12. 8.2.5 Zoetis Recent Developments
  13. 8.3 Boehringer Ingelheim
  14. 8.3.1 Boehringer Ingelheim Company Information
  15. 8.3.2 Boehringer Ingelheim Business Overview
  16. 8.3.3 Boehringer Ingelheim Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Boehringer Ingelheim Veterinary Vaccine Product Portfolio
  18. 8.3.5 Boehringer Ingelheim Recent Developments
  19. 8.4 Ceva
  20. 8.4.1 Ceva Company Information
  21. 8.4.2 Ceva Business Overview
  22. 8.4.3 Ceva Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Ceva Veterinary Vaccine Product Portfolio
  24. 8.4.5 Ceva Recent Developments
  25. 8.5 CAHIC
  26. 8.5.1 CAHIC Company Information
  27. 8.5.2 CAHIC Business Overview
  28. 8.5.3 CAHIC Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 CAHIC Veterinary Vaccine Product Portfolio
  30. 8.5.5 CAHIC Recent Developments
  31. 8.6 HVRI
  32. 8.6.1 HVRI Company Information
  33. 8.6.2 HVRI Business Overview
  34. 8.6.3 HVRI Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 HVRI Veterinary Vaccine Product Portfolio
  36. 8.6.5 HVRI Recent Developments
  37. 8.7 Ringpu Biology
  38. 8.7.1 Ringpu Biology Company Information
  39. 8.7.2 Ringpu Biology Business Overview
  40. 8.7.3 Ringpu Biology Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Ringpu Biology Veterinary Vaccine Product Portfolio
  42. 8.7.5 Ringpu Biology Recent Developments
  43. 8.8 Yebio
  44. 8.8.1 Yebio Company Information
  45. 8.8.2 Yebio Business Overview
  46. 8.8.3 Yebio Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Yebio Veterinary Vaccine Product Portfolio
  48. 8.8.5 Yebio Recent Developments
  49. 8.9 DHN
  50. 8.9.1 DHN Company Information
  51. 8.9.2 DHN Business Overview
  52. 8.9.3 DHN Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 DHN Veterinary Vaccine Product Portfolio
  54. 8.9.5 DHN Recent Developments
  55. 8.10 WINSUN
  56. 8.10.1 WINSUN Company Information
  57. 8.10.2 WINSUN Business Overview
  58. 8.10.3 WINSUN Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 WINSUN Veterinary Vaccine Product Portfolio
  60. 8.10.5 WINSUN Recent Developments
  61. 8.11 Elanco
  62. 8.11.1 Elanco Company Information
  63. 8.11.2 Elanco Business Overview
  64. 8.11.3 Elanco Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Elanco Veterinary Vaccine Product Portfolio
  66. 8.11.5 Elanco Recent Developments
  67. 8.12 Virbac
  68. 8.12.1 Virbac Company Information
  69. 8.12.2 Virbac Business Overview
  70. 8.12.3 Virbac Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Virbac Veterinary Vaccine Product Portfolio
  72. 8.12.5 Virbac Recent Developments
  73. 8.13 Jinyu Bio-Technology
  74. 8.13.1 Jinyu Bio-Technology Company Information
  75. 8.13.2 Jinyu Bio-Technology Business Overview
  76. 8.13.3 Jinyu Bio-Technology Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Jinyu Bio-Technology Veterinary Vaccine Product Portfolio
  78. 8.13.5 Jinyu Bio-Technology Recent Developments
  79. 8.14 ChengDu Tecbond
  80. 8.14.1 ChengDu Tecbond Company Information
  81. 8.14.2 ChengDu Tecbond Business Overview
  82. 8.14.3 ChengDu Tecbond Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 ChengDu Tecbond Veterinary Vaccine Product Portfolio
  84. 8.14.5 ChengDu Tecbond Recent Developments
  85. 8.15 CAVAC
  86. 8.15.1 CAVAC Company Information
  87. 8.15.2 CAVAC Business Overview
  88. 8.15.3 CAVAC Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 CAVAC Veterinary Vaccine Product Portfolio
  90. 8.15.5 CAVAC Recent Developments
  91. 8.16 Kyoto Biken Laboratories
  92. 8.16.1 Kyoto Biken Laboratories Company Information
  93. 8.16.2 Kyoto Biken Laboratories Business Overview
  94. 8.16.3 Kyoto Biken Laboratories Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Kyoto Biken Laboratories Veterinary Vaccine Product Portfolio
  96. 8.16.5 Kyoto Biken Laboratories Recent Developments
  97. 8.17 FATRO
  98. 8.17.1 FATRO Company Information
  99. 8.17.2 FATRO Business Overview
  100. 8.17.3 FATRO Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 FATRO Veterinary Vaccine Product Portfolio
  102. 8.17.5 FATRO Recent Developments
  103. 8.18 Vaksindo
  104. 8.18.1 Vaksindo Company Information
  105. 8.18.2 Vaksindo Business Overview
  106. 8.18.3 Vaksindo Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Vaksindo Veterinary Vaccine Product Portfolio
  108. 8.18.5 Vaksindo Recent Developments
  109. 8.19 Bio-Labs
  110. 8.19.1 Bio-Labs Company Information
  111. 8.19.2 Bio-Labs Business Overview
  112. 8.19.3 Bio-Labs Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Bio-Labs Veterinary Vaccine Product Portfolio
  114. 8.19.5 Bio-Labs Recent Developments
  115. 8.20 Avimex Animal Health
  116. 8.20.1 Avimex Animal Health Company Information
  117. 8.20.2 Avimex Animal Health Business Overview
  118. 8.20.3 Avimex Animal Health Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Avimex Animal Health Veterinary Vaccine Product Portfolio
  120. 8.20.5 Avimex Animal Health Recent Developments
  121. 8.21 MEVAC
  122. 8.21.1 MEVAC Company Information
  123. 8.21.2 MEVAC Business Overview
  124. 8.21.3 MEVAC Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  125. 8.21.4 MEVAC Veterinary Vaccine Product Portfolio
  126. 8.21.5 MEVAC Recent Developments
  127. 8.22 Biovac
  128. 8.22.1 Biovac Company Information
  129. 8.22.2 Biovac Business Overview
  130. 8.22.3 Biovac Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  131. 8.22.4 Biovac Veterinary Vaccine Product Portfolio
  132. 8.22.5 Biovac Recent Developments
  133. 8.23 Atafen
  134. 8.23.1 Atafen Company Information
  135. 8.23.2 Atafen Business Overview
  136. 8.23.3 Atafen Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  137. 8.23.4 Atafen Veterinary Vaccine Product Portfolio
  138. 8.23.5 Atafen Recent Developments
  139. 8.24 Dyntec
  140. 8.24.1 Dyntec Company Information
  141. 8.24.2 Dyntec Business Overview
  142. 8.24.3 Dyntec Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  143. 8.24.4 Dyntec Veterinary Vaccine Product Portfolio
  144. 8.24.5 Dyntec Recent Developments
  145. 8.25 BioTestLab
  146. 8.25.1 BioTestLab Company Information
  147. 8.25.2 BioTestLab Business Overview
  148. 8.25.3 BioTestLab Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  149. 8.25.4 BioTestLab Veterinary Vaccine Product Portfolio
  150. 8.25.5 BioTestLab Recent Developments
  151. 8.26 RVSRI
  152. 8.26.1 RVSRI Company Information
  153. 8.26.2 RVSRI Business Overview
  154. 8.26.3 RVSRI Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  155. 8.26.4 RVSRI Veterinary Vaccine Product Portfolio
  156. 8.26.5 RVSRI Recent Developments
  157. 8.27 Medion
  158. 8.27.1 Medion Company Information
  159. 8.27.2 Medion Business Overview
  160. 8.27.3 Medion Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  161. 8.27.4 Medion Veterinary Vaccine Product Portfolio
  162. 8.27.5 Medion Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Veterinary Vaccine Value Chain Analysis
  2. 9.1.1 Veterinary Vaccine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Veterinary Vaccine Production Mode & Process
  6. 9.2 Veterinary Vaccine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Veterinary Vaccine Distributors
  9. 9.2.3 Veterinary Vaccine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst